Neutral impactIPO
Sonaselection India shares list at 3% premium on BSE, NSE; should you buy, sell or hold?
Moneycontrol.com 1 hr ago·24 Sept 2026, 4:21 am
Sonaselection India has successfully listed its shares on both the BSE and NSE at a premium of 3%. This positive reception from the market indicates strong initial demand for the company's IPO. The listing price reflects the confidence investors have in the firm's business model and growth prospects at this stage.
For investors, a listing at a premium is generally seen as a positive sign, though it does not guarantee future performance. The stock's price will now be determined by market forces, and investors should evaluate the company's fundamentals rather than just the listing gain. It is crucial to conduct your own research before making any investment decisions.
Moving forward, investors should monitor the stock's trading volume and price movement in the coming sessions. Watch for any announcements regarding the company's future expansion plans or financial results, as these factors will play a key role in determining the stock's long-term trajectory.
Excerpt from Moneycontrol.com
Check eligibility in just 5 mins Up to ₹50 lakhs | Starts at 9.99% Sonaselection India debuted at 3% premium on NSE. Proceeds to repay debt and fund capex. in your portfolio by Vishal Malkan Shares of Sonaselection India made a decent debut on the stock exchanges on September 24, listing at a premium of around 3% over…Read the original at Moneycontrol.com
Key takeaways
- Category: IPO.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.
